Celgene to acquire Abraxis
LOS ANGELES Abraxis BioScience shareholders have approved an acquisition of the company by Celgene, Celgene said Wednesday.
The $3 billion acquisition will give Celgene control of Abraxis’ cancer therapies and its anti-tumor Nab technology.
“We appreciate this vote of support by Abraxis’ shareholders and look forward to bringing together the talent and resources of both organizations unified in vision, mission and values and aligned through a commitment to improving the lives of patients worldwide,” Celgene CEO Bob Hugin said in a statement.
NACDS Foundation supports new NEHI report on care teams, medication adherence
ALEXANDRIA, Va. A report by the New England Healthcare Institute that addressed the role of care teams in improving medication adherence among patients has received support from the charitable arm of the National Association of Chain Drug Stores.
The NACDS Foundation on Wednesday announced its support of the report "Medication Adherence and Care Teams: A Call for Demonstration Projects," which underscored the role of care teams — specifically, a “virtual care team,” a collaboration between small physician practices, community pharmacists and other external health professionals — in improving public health.
“Existing medical evidence supports the idea that team-based care can provide superior treatment of chronic conditions. Care teams are integral to the patient-centered medical home, and to other models of improved patient care that are designed to improve efficiency, affordability and, ultimately, patient outcomes,” the report noted.
NACDS Foundation president Edith Rosato applauded NEHI’s report, which is part of the "Thinking Outside the Pillbox" series of reports that examine medication adherence.
“When medications are not taken correctly, public health suffers,” Rosato said. “This report continues land-breaking work by NEHI in raising awareness of this critical health challenge, and identifying potential solutions.”
Safeway pharmacies offering pertussis booster vaccine
PLEASANTON, Calif. — Safeway pharmacies in California are responding to the state’s whooping cough (pertussis) emergency and now are offering Adacel, a booster vaccine for people ages 11 through 64 years, the grocer announced Wednesday.
The Adacel vaccine is available at all Safeway, Vons and Pavilions pharmacies on a walk-in basis, the company stated.
California’s incidences of whooping cough have reached a 60-year high, with more than 5,200 confirmed, suspected and possible cases this year, according to the California Department of Public Health. Because of the sudden increase, Gov. Arnold Schwarzenegger recently signed a bill requiring 7th-grade through 12th-grade students to get a whooping cough booster shot before the start of the next school year.
Agrowing number of insurance plans cover the whooping cough booster vaccine, decreasing or eliminating out-of-pocket costs, as well as eliminating the cost of a doctor’s office visit.